Login / Signup

Combining clinical, radiological and genetic approaches to pneumothorax management.

Hannah L GrimesSimon HoldenJudith BabarSumit KariaMaria Ta WetscherekAllanah BarkerJurgen HerreMartin D KnolleEamonn R Mahernull nullStefan John Marciniak
Published in: Thorax (2021)
Familial spontaneous pneumothorax (FSP) accounts for 10% of primary spontaneous pneumothoraces. Appropriate investigation of FSP enables early diagnosis of serious monogenic diseases and the practice of precision medicine. Here, we show that a pneumothorax genetics multidisciplinary team (MDT) can efficiently diagnose a range of syndromic causes of FSP. A sizeable group (73.6%) of clinically unclassifiable FSPs remains. Using whole genome sequencing we demonstrate that most of these cases are not known monogenic disorders. Therefore, clinico-radiological assessment by an MDT has high sensitivity for currently known clinically important monogenic causes of FSP, which has relevance for the design of efficient pneumothorax services.
Keyphrases
  • healthcare
  • primary care
  • quality improvement
  • palliative care
  • genome wide
  • intellectual disability
  • dna methylation
  • autism spectrum disorder